Literature DB >> 1592072

Thiamin contents of cerebrospinal fluid, plasma and erythrocytes in cerebellar ataxias.

M Poloni1, P Mazzarello, U Laforenza, C Caramella, C Patrini.   

Abstract

Free thiamin and thiamin monophosphate have been found in the cerebrospinal fluid, plasma and in erythrocytes of patients suffering from ataxia of different origins. In erythrocytes, thiamin pyrophosphate was also measured. In a limited number of cases, uptake of 14C-thiamin by erythrocytes was found as well. Controls were hospitalized patients affected by chronic neurological diseases without any clinical sign of thiamin deficiency. The results showed a significant decrease in thiamin and thiamin monophosphate in the cerebrospinal fluid and in the plasma of ataxic subjects, in comparison to controls. In erythrocytes, only thiamin pyrophosphate levels had decreased. The uptake of 14C-thiamin by erythrocytes was similar in both ataxic and control groups. These results were comparable to those observed in thiamin-deficient individuals, like alcoholic patients, and prompted further investigation into thiamin metabolism in these diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592072     DOI: 10.1159/000116814

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  3 in total

1.  Long-term treatment with thiamine as possible medical therapy for Friedreich ataxia.

Authors:  Antonio Costantini; Tiziana Laureti; Maria Immacolata Pala; Marco Colangeli; Simona Cavalieri; Elisa Pozzi; Alfredo Brusco; Sandro Salvarani; Carlo Serrati; Roberto Fancellu
Journal:  J Neurol       Date:  2016-08-03       Impact factor: 4.849

2.  Subacute sensory ataxia and optic neuropathy with thiamine deficiency.

Authors:  Marco Spinazzi; Corrado Angelini; Cesare Patrini
Journal:  Nat Rev Neurol       Date:  2010-03-23       Impact factor: 42.937

3.  Thiamine and spinocerebellar ataxia type 2.

Authors:  Antonio Costantini; Maria Immacolata Pala; Marco Colangeli; Serena Savelli
Journal:  BMJ Case Rep       Date:  2013-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.